Related Experiment Video
Updated: Jan 13, 2026

Development of a Virtual Reality Assessment of Everyday Living Skills
Published on: April 23, 2014
Research Support for U.S. Psychiatrists From Pharmaceutical and Medical Device Companies, 2015-2022
John L Havlik1, Syed Wahid2, Kalea Hidalgo2
1Department of Psychiatry and Behavioral Sciences, Stanford University School of Medicine, Stanford.
Psychiatrists received substantial industry funding for research, totaling over $98 million. This funding was concentrated among a small percentage of principal investigators and a few companies, highlighting potential financial conflicts of interest in psychiatric research.
Area of Science:
- Psychiatry
- Medical Industry Funding
- Research Finance
Background:
- Growing scrutiny surrounds potential financial conflicts of interest for psychiatrists receiving medical industry funding.
- Industry funding is a crucial resource for psychiatrist-scientists, especially with unpredictable government grants.
Purpose of the Study:
- To investigate the scope and concentration of industry research payments to psychiatrists.
- To analyze payments from pharmaceutical and medical device companies between 2015-2022.
Main Methods:
- Utilized National Plan and Provider Enumeration System data from 2015-2022.
- Identified 57,365 psychiatrists, focusing on principal investigators receiving industry research support.
Main Results:
- 0.85% of psychiatrists (488 principal investigators) received $98,189,901 in industry research funding.
- Median annual payment was $21,749.
- Funding was highly concentrated among a few companies and institutions.
Conclusions:
- A small number of psychiatrists and institutions receive a significant portion of industry research funding.
- This concentration warrants attention regarding potential conflicts of interest in psychiatric research.
- Industry funding remains vital for psychiatric research despite financial scrutiny.
More Related Videos
08:36The Immersive Cleveland Clinic Virtual Reality Shopping Platform for the Assessment of Instrumental Activities of Daily Living
Published on: July 28, 2022
09:29Investigating Drivers of Antireward in Addiction Behavior with Anatomically Specific Single-Cell Gene Expression Methods
Published on: August 4, 2022
Related Concept Videos
Pharmacovigilance
This process, termed pharmacovigilance, aims to detect, evaluate, and minimize harmful effects related to medication use. The data collection for pharmacovigilance depends on spontaneous reporting systems, where healthcare professionals or patients voluntarily report suspected ADRs.
In some cases, there...
Clinical Trials: Overview
Psychosurgery
Historical Development of Psychosurgery
In the 1930s, Portuguese neurologist Antonio Egas Moniz introduced a surgical procedure designed...
Diagnostic and Statistical Manual of Mental Disorders (DSM)
Drug Regulation
Clinical Trials
There are four phases in a clinical trial. A phase one...